REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Enamed Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: Enamed Sp. z o.o. Profile Updated: April 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Enamed is a medical company. The company specializes in gastroenterology and internal diseases and operates a modern endoscopic workshop with well-equipped medical offices. Enamed employs a team of doctors with expertise in endoscopy of the Polish digestive tract.

Headquarters
Ul. Armii Krajowej 15
Piotrkow Trybunalski; Lodzkie; Postal Code: 97-300

Contact Details: Purchase the Enamed Sp. z o.o. report to view the information.

Website: http://www.enamed.pl

Basic Information
Total Employees:
Purchase the Enamed Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Enamed Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Enamed Sp. z o.o. report to view the information.
Incorporation Date:
January 20, 2012
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Enamed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
8.24%▲
Total operating revenue
8.24%▲
Operating profit (EBIT)
-43.01%▼
EBITDA
-4.49%▼
Net Profit (Loss) for the Period
-42.28%▼
Total assets
8.79%▲
Total equity
22.57%▲
Operating Profit Margin (ROS)
-9.16%▼
Net Profit Margin
-8.05%▼
Return on Equity (ROE)
-20.69%▼
Quick Ratio
3.27%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo